Study reveals long-term consequences of atrial fibrillation

The lifetime risk of atrial fibrillation (a heart condition that causes an irregular and often abnormally fast heart rate) has increased from one in four to one in three over the past two decades, finds a study from Denmark in The BMJ today.

Cassava Sciences collaborator charged with defrauding NIH in grants supporting its Alzheimer’s drug

A Cassava Sciences collaborator and paid consultant has been indicted by a federal grand jury on charges of defrauding the National Institutes of Health in

June 28, 2024

FDA drafts new guidance on manufacturing cell and gene therapies, postmarket trial noncompliance

The FDA on Thursday released two new draft guidance documents related to the manufacture of cell and gene therapies, one directing manufacturers to carry out

July 14, 2023

Certain Cancer Survivors More Likely to Have Substance Use Disorder

The prevalence of substance use disorder (SUD) among adult cancer survivors varies depending on the particular cancer type, according to results from a cross-sectional study.

January 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.